Meaghan Lavery

Meaghan Lavery is a Researcher in the Department of Psychiatry at Yale School of Medicine. Her work focuses on the intersection of stress, addiction, and pharmacological interventions, particularly in smoking cessation and substance abuse treatment. She has contributed to studies exploring the effects of medications like carvedilol and doxazosin on stress-induced smoking behaviors.

Her research spans topics such as motivational interviewing for treatment adherence, clinician attitudes toward treatment manuals, and the neurobiological mechanisms linking stress to tobacco use. Lavery’s publications highlight methodological rigor in clinical trials and behavioral interventions, with a focus on translational research to improve mental health outcomes.